Can a drug and probiotic combo turn back the clock on aging?
NCT ID NCT07363057
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial is testing whether a combination of a drug (GI-102) and a probiotic supplement (GIB-7) can improve markers of aging in the immune system. The study includes 15 healthy adults and cancer survivors aged 18 to 80. Participants will receive either the active combination or a placebo for 8 weeks, and researchers will measure changes in immune cells, sleep quality, and safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GI-102 (efzilonkofusp alfa) plus GIB-7 (synbiotic formula)
What this could lead to
If successful, this could point toward a treatment that slows or reverses some aspects of immune aging, potentially improving health in older adults and cancer survivors.
What could go wrong
This is a very small early-phase trial with only 15 participants, so results may not apply broadly. The combination therapy is new, and side effects or lack of effectiveness are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELDERLY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novatrials
RECRUITINGCharlestown, New South Wales, 2290, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Southern Oncology Clinical Research Unit
RECRUITINGAdelaide, South Australia, 5042, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact